Lauren Hare
Physician Assistant · Dunkirk, MDNPI 1063055432
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 8.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$291
- Pfizer$261
- AstraZeneca$207
- Daiichi Sankyo Inc.$192
- GSK$172
- Takeda Pharmaceuticals U.S.A., Inc.$168
- plus $2K from 36 others
What the payments were for
- Food & beverage$3,20998%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,289 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PomalystPomalidomide | 21 | $457,017 |
| XtandiEnzalutamide | 21 | $255,628 |
| Lenalidomide | 11 | $178,828 |
| CalquenceAcalabrutinib Maleate | 12 | $173,192 |
| EliquisApixaban | 128 | $141,447 |
| XareltoRivaroxaban | 27 | $34,180 |
| Enoxaparin Sodium | 21 | $6,618 |
| Exemestane | 16 | $4,337 |
| Imatinib Mesylate | 21 | $3,241 |
| Anastrozole | 49 | $1,531 |
| Tamoxifen Citrate | 23 | $816 |
| Omeprazole | 41 | $705 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $680 |
| Letrozole | 27 | $672 |
| Levothyroxine Sodium | 56 | $630 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Pomalyst | $133 | $457,01721 claims |
| Astellas Pharma US IncXtandi | $26 | $255,62821 claims |
| AstraZenecaCalquence | $207 | $173,19212 claims |
| PfizerEliquis | $261 | $141,447128 claims |
| Johnson & JohnsonXarelto | $291 | $34,18027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Dunkirk
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
- Lisa FoxAnnapolis$26K
- Praveena GadamBaltimore$24K
- Jinhui YuanFrederick$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.